Aslan Pharmaceuticals Probability of Future Stock Price Finishing Over 0.6
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Aslan |
Aslan Pharmaceuticals Target Price Odds to finish over 0.6
The tendency of Aslan Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.60 | 90 days | 0.60 | close to 99 |
Based on a normal probability distribution, the odds of Aslan Pharmaceuticals to move above the current price in 90 days from now is close to 99 (This Aslan Pharmaceuticals probability density function shows the probability of Aslan Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Aslan Pharmaceuticals has a beta of -0.65. This suggests as returns on the benchmark increase, returns on holding Aslan Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Aslan Pharmaceuticals is likely to outperform the market. Additionally Aslan Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Aslan Pharmaceuticals Price Density |
| Price |
Predictive Modules for Aslan Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aslan Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Aslan Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Aslan Pharmaceuticals is not an exception. The market had few large corrections towards the Aslan Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aslan Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aslan Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.24 | |
β | Beta against Dow Jones | -0.65 | |
σ | Overall volatility | 0.80 | |
Ir | Information ratio | -0.26 |
Aslan Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aslan Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aslan Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aslan Pharmaceuticals is not yet fully synchronised with the market data | |
| Aslan Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aslan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12 M. Net Loss for the year was (44.22 M) with profit before overhead, payroll, taxes, and interest of 79.82 M. | |
| Aslan Pharmaceuticals currently holds about 78.12 M in cash with (46.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Aslan Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aslan Stock often depends not only on the future outlook of the current and potential Aslan Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aslan Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.4 M | |
| Cash And Short Term Investments | 21.3 M |
Aslan Pharmaceuticals Technical Analysis
Aslan Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Aslan Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aslan Pharmaceuticals. In general, you should focus on analyzing Aslan Stock price patterns and their correlations with different microeconomic environments and drivers.
Aslan Pharmaceuticals Predictive Forecast Models
Aslan Pharmaceuticals' time-series forecasting models is one of many Aslan Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aslan Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Aslan Pharmaceuticals
Checking the ongoing alerts about Aslan Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aslan Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Aslan Pharmaceuticals is not yet fully synchronised with the market data | |
| Aslan Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aslan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12 M. Net Loss for the year was (44.22 M) with profit before overhead, payroll, taxes, and interest of 79.82 M. | |
| Aslan Pharmaceuticals currently holds about 78.12 M in cash with (46.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |